Brief: Kailera Therapeutics Announces Pricing Of Initial Public Offering
17/04/2026 24:29
April 16 (Reuters) - KAILERA THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING KAILERA THERAPEUTICS: PRICES INITIAL PUBLIC OFFERING OF 39,062,500 SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $16.00 PER SHARE Source text: ID:nGNX1fnt9R Further company coverage: KLRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kailera Therapeutics
See all newsChina biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
China biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Kailera Therapeutics Announces Completion Of Enrollment In Kainetic Global Phase 3 Clinical Program Of Glp-1/Gip Receptor Dual Agonist Ribupatide Injection